{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T23:33:35Z","timestamp":1725752015864},"publisher-location":"Boston, MA","reference-count":7,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461361053"},{"type":"electronic","value":"9781461525844"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1995]]},"DOI":"10.1007\/978-1-4615-2584-4_85","type":"book-chapter","created":{"date-parts":[[2013,10,13]],"date-time":"2013-10-13T03:29:42Z","timestamp":1381634982000},"page":"391-394","source":"Crossref","is-referenced-by-count":5,"title":["Biochemical and Immunological Status Following Gene Therapy and PEG-ADA Therapy for Adenosine Deaminase (ADA) Deficiency"],"prefix":"10.1007","author":[{"given":"Lynette D.","family":"Fairbanks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Anne","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Hoogerbrugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor W.","family":"van Beusechem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinko","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Moseley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland J.","family":"Levinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert B.","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"85_CR1","first-page":"491","volume":"70","author":"G Morgan","year":"1987","unstructured":"G. Morgan, R.J. Levinsky, K. Hugh-Jones, L.D. Fairbanks, G.S. Morris and H.A. Simmonds Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency. Clin exp Immunol 70: 491(1987)","journal-title":"Clin exp Immunol"},{"key":"85_CR2","volume-title":"Adenosine deaminase deficiency and purine nucleoside Phosphorylase deficiency. Chapter 40, in The Metabolic Basis of Inherited Disease","author":"NM Kredich","year":"1989","unstructured":"N.M. Kredich and M.S.H Ershfield Adenosine deaminase deficiency and purine nucleoside Phosphorylase deficiency. Chapter 40, in The Metabolic Basis of Inherited Disease,. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, eds., McGraw-Hill, New York, 6th edition (1989).","edition":"6"},{"key":"85_CR3","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1016\/0006-2952(85)90734-8","volume":"34","author":"A Goday","year":"1985","unstructured":"A. Goday, H.A. Simmonds, G.S. Morris and L.D. Fairbanks. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency. Biochem Pharmacol 34: 3561(1985)","journal-title":"Biochem Pharmacol"},{"key":"85_CR4","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/0140-6736(93)90910-9","volume":"341","author":"CL Shovlin","year":"1993","unstructured":"C.L. Shovlin, A.D.B. Webster, L.D. Fairbanks, H.A. Simmonds, S. Deacock, R. Lechler, I. Roberts and J.M.B. Hughes Adult presentation of inherited adenosine deaminase deficiency. Lancet 341: 1472 (1993).","journal-title":"Lancet"},{"key":"85_CR5","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1203\/00006450-199333011-00009","volume":"33","author":"MS Hershfield","year":"1993","unstructured":"M.S. Hershfield, S. Chaffee and R.U Sorensen. Enzyme replacement therapy with polyethylene glycol-adenosine deaminase and adenosine deaminase deficiency. Pediatr. Res. 33: S42 (1993)","journal-title":"Pediatr. Res."},{"key":"85_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1089\/hum.1993.4.4-521","volume":"4","author":"RM Blaese","year":"1993","unstructured":"R.M. Blaese et al Treatment of SCID due to ADA deficiency with autologous lymphocytes transduced with the ADA gene. Human Gene Therapy 4: 521 (1993).","journal-title":"Human Gene Therapy"},{"key":"85_CR7","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.1073\/pnas.89.16.7640","volume":"89","author":"VW Beusechem van","year":"1992","unstructured":"V.W. van Beusechem, A. Kukler, P.J. Heidt and D. Valerio. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc. Natl Acad. Sci USA 89: 7640 (1992).","journal-title":"Proc. Natl Acad. Sci USA"}],"container-title":["Advances in Experimental Medicine and Biology","Purine and Pyrimidine Metabolism in Man VIII"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-2584-4_85","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:40:51Z","timestamp":1558597251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-2584-4_85"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995]]},"ISBN":["9781461361053","9781461525844"],"references-count":7,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-2584-4_85","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[1995]]}}}